July 2019: Netherlands Regulatory Update

The Netherlands Central Committee on Research Involving Human Subjects (CCMO) posted a news release 29 July titled Publish Your Clinical Trial Results in ToetsingOnline and in EudraCT Database. This news item was prompted by a joint letter from the European Commission, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA), to remind sponsors that, as of July 2014, they are legally required to publish results of research with a medicinal product conducted in the European Union, in the EU Clinical Trials Database (EudraCT) within one year of the end of a clinical trial. In addition, CCMO would like to draw your attention to the fact that the results of all research subject to WMO must also be submitted to ToetsingOnline.

Leave a Reply